Complement system in cancer: friend or foe of immunotherapy. [PDF]
Shah HK +6 more
europepmc +1 more source
Synthesis and crystal structure of ethyl 2-(1,3-benzo-thia-zol-2-yl)-1-oxo-1<i>H</i>-pyrido[2,1-<i>b</i>][1,3]benzo-thia-zole-4-carboxyl-ate. [PDF]
Elboshi HA +3 more
europepmc +1 more source
Basic weapons to degrade C3a and C5a [PDF]
J H, Foley, E M, Conway
openaire +2 more sources
Synthesis and structure of (7a<i>RS</i>)-4-chloro-6-(4-methyl-phen-yl)-6,7,7a,8-tetra-hydro-5<i>H</i>-indeno-[5,6-<i>b</i>]furan-5-one, a fused-ring system arising from a new variant of the IMDAV reaction. [PDF]
Alekseeva KA +6 more
europepmc +1 more source
The insider's perspective: The intracellular complosome and immune cell dynamics in cancer. [PDF]
Bennion A, Lysaght J, Lynam-Lennon N.
europepmc +1 more source
Crystal structure and Hirshfeld surface analysis of 2-oxo-4-phenyl-2,5,6,7,8,9-hexa-hydro-1<i>H</i>-cyclohepta-[<i>b</i>]pyridine-3-carbo-nitrile. [PDF]
Rajapandiyan U +4 more
europepmc +1 more source
5-{4-[(1<i>R</i>,3<i>S</i>,4<i>S</i>)-Neomenth-yloxy]phen-yl}-1<i>H</i>-tetra-zole. [PDF]
Detert H, Schollmeyer D.
europepmc +1 more source
Correction: Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma. [PDF]
Jiang F +9 more
europepmc +1 more source
Urokinase Promotes Redundantly Intratubular C3a-Formation But Not ENaC-Driven Hypertension in DOCA/Salt Kidney Injury. [PDF]
Bach ML +6 more
europepmc +1 more source

